TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
SER

Serina Therapeutics Inc

Healthcare · Biotechnology

2.30$ +2.7% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow SER
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-19.3% -21.6% +77.8% +32.0% -97.3% +83.6% +46.9% +115.6% -62.4%
-91.4% +251.6% +10,280.0% +46.2%
-40.6% -72.8% -294.3% -4,193.8%
-95.7% +189,200.0% -66.1% -96.9% +442.2% -91.1% +5,105.5% -95.6% +168.2%
+26,440.0% -127.2% -94.5% +19.1% -151.4% -95.6% +168.2%
+25.0%
+668.7% -71.4% +70.9%
+83.0% -54.8% +4.4% -4.9% -81.9% +21.8% +667.3% +31.2% +31.8%
-109.4% +3,160.1% -155.7%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?